CASTLEARK MANAGEMENT LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1106832
CHICAGO, IL
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,129,346
+$2,389,544 QoQ
Shares Held
174,032
-4.1% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#50
of 264 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CASTLEARK MANAGEMENT LLC holds $19,961,382 across 2 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (55.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
174,032 | $11,129,346 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
358,880 | $8,832,036 |
All Filings in KNSA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,129,346 | 174,032 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,739,802 | 181,512 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,927,920 | 192,192 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,159,680 | 158,632 | Shares | Sole | 2025-11-17 | |
| 2024-09-30 | $4,178,328 | 167,200 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||